Lars Mueller,* Alexandra Constantin,† Harsimran Singh,† Steph Habif †
To determine how an advanced closed-loop system like Control-IQ® technology t:slim X2™ insulin pump can assist people with diabetes to better manage their time below range (TBR) targets while optimizing glycemic control.
We examined sensor TBR metrics for people with with type 1 diabetes (T1D) 30 days prior to starting Control-IQ technology and after seven weeks of using Control-IQ technology, focusing on glycemic outcomes.
Using Control-IQ technology, participants demonstrated significant reduction in both Level 1 (<70mg/dL) and Level 2 (<54mg/dL) hypoglycemia.
Use of the t:slim X2 pump with Control-IQ technology demonstrated clinically relevant reduction in hypoglycemia with improved sensor time in range in people with T1D within a few weeks.